There is one clinical trial.
A pilot study to investigate the effects of the prone positioning (PP) on hospital patients diagnosed with COVID-19 pneumonia. Investigators that early self-proning may prevent intubation and improve mortality in patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2). Up to 100 participants with a primary diagnosis of confirmed COVID-19 pneumonia will be enrolled to the study. All participants will be screened and those that meet inclusion and exclusion criteria will be enrolled to one of two groups: one with prone positioning (on the belly) and the other with standard supine positioning (on the back). The patient and nursing staff will monitor times spent in various positions. Outcome measures include incidence of intubation, max oxygen requirements, length of hospital stay, ventilator-free days, worsening of oxygenation saturation, and mortality.
Description: Incidence of intubationMeasure: Incidence of intubation Time: Through study completion, an average of 6 days
Description: Measure of maximum oxygen requirementsMeasure: Maximum oxygen requirement Time: Through study completion, an average of 6 days
Description: Measured in days of hospitalizationMeasure: Length of Stay Time: Through study completion, an average of 6 days
Description: Measured in days not on a ventilatorMeasure: Ventilator-free days Time: Through study completion, an average of 6 days
Description: Whether or not the participant met treatment failure descriptionsMeasure: Treatment failure of prone positioning due to worsening SpO2 status while prone Time: Through study completion, an average of 6 days
Description: Whether or not the participant died while hospitalizedMeasure: Mortality Time: Through study completion, an average of 6 days
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports